ARROWHEAD PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Earnings Per Share, Basic and Diluted of -$0.12 per share for the 3-month period ending 2018-09-30, per its 10-K filed 2018-12-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2018-12-11
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2018-09-30 was -$0.12.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2018-06-30 was -$0.18.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2018-03-31 was -$0.18.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2017-12-31 was -$0.18.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.65.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2017 was -$0.47.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2016 was -$1.34.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2015 was -$1.60.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$0.12 10-K · filed 2018-12-11 | -$0.30 derived: net income ÷ weighted average shares · filed 2020-11-23 | -$0.48 derived: net income ÷ weighted average shares · filed 2020-11-23 | -$0.65 10-K · filed 2018-12-11 |
| 2018-06-30 | -$0.18 10-K · filed 2018-12-11 | -$0.36 derived: net income ÷ weighted average shares · filed 2019-08-05 | -$0.53 10-Q · filed 2018-08-07 | -$0.68 derived: net income ÷ weighted average shares · filed 2019-08-05 |
| 2018-03-31 | -$0.18 10-K · filed 2018-12-11 | -$0.35 10-Q · filed 2018-05-08 | -$0.50 derived: net income ÷ weighted average shares · filed 2019-05-08 | -$0.57 derived: net income ÷ weighted average shares · filed 2019-05-08 |
| 2017-12-31 | -$0.18 10-K · filed 2018-12-11 | -$0.32 derived: net income ÷ weighted average shares · filed 2019-02-07 | -$0.39 derived: net income ÷ weighted average shares · filed 2019-02-07 | -$0.47 derived: net income ÷ weighted average shares · filed 2019-02-07 |
| 2017-09-30 | -$0.14 10-K · filed 2018-12-11 | -$0.22 derived: net income ÷ weighted average shares · filed 2018-12-11 | -$0.30 derived: net income ÷ weighted average shares · filed 2018-12-11 | -$0.47 10-K · filed 2018-12-11 |
| 2017-06-30 | -$0.07 10-K · filed 2018-12-11 | -$0.15 derived: net income ÷ weighted average shares · filed 2018-08-07 | -$0.32 10-Q · filed 2018-08-07 | -$0.64 derived: net income ÷ weighted average shares · filed 2018-12-11 |
| 2017-03-31 | -$0.08 10-K · filed 2018-12-11 | -$0.25 10-Q · filed 2018-05-08 | -$0.57 derived: net income ÷ weighted average shares · filed 2018-12-11 | -$0.88 derived: net income ÷ weighted average shares · filed 2018-12-11 |
| 2016-12-31 | -$0.17 10-K · filed 2018-12-11 | -$0.50 derived: net income ÷ weighted average shares · filed 2018-12-11 | -$0.82 derived: net income ÷ weighted average shares · filed 2018-12-11 | -$1.16 derived: net income ÷ weighted average shares · filed 2018-12-11 |
| 2016-09-30 | -$0.34 10-K · filed 2017-12-12 | -$0.67 derived: net income ÷ weighted average shares · filed 2018-12-11 | -$1.01 derived: net income ÷ weighted average shares · filed 2018-12-11 | -$1.34 10-K · filed 2018-12-11 |
| 2016-06-30 | -$0.32 10-K · filed 2017-12-12 | -$0.67 derived: net income ÷ weighted average shares · filed 2017-12-12 | -$1.00 10-Q · filed 2017-08-03 | -$1.41 derived: net income ÷ weighted average shares · filed 2017-12-12 |
| 2016-03-31 | -$0.35 10-K · filed 2017-12-12 | -$0.67 10-Q · filed 2017-05-03 | -$1.09 derived: net income ÷ weighted average shares · filed 2017-12-12 | -$1.36 derived: net income ÷ weighted average shares · filed 2017-12-12 |
| 2015-12-31 | -$0.32 10-K · filed 2017-12-12 | -$0.74 derived: net income ÷ weighted average shares · filed 2017-12-12 | -$1.01 derived: net income ÷ weighted average shares · filed 2017-12-12 | -$1.51 derived: net income ÷ weighted average shares · filed 2017-12-12 |
| 2015-09-30 | -$0.42 10-K · filed 2016-12-14 | -$0.68 derived: net income ÷ weighted average shares · filed 2017-12-12 | -$1.19 derived: net income ÷ weighted average shares · filed 2017-12-12 | -$1.60 10-K · filed 2017-12-12 |
| 2015-06-30 | -$0.27 10-K · filed 2016-12-14 | -$0.77 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$1.19 10-Q · filed 2016-08-09 | -$1.60 derived: net income ÷ weighted average shares · filed 2016-12-14 |
| 2015-03-31 | -$0.51 10-K · filed 2016-12-14 | -$0.93 10-Q · filed 2016-05-10 | -$1.34 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$1.58 derived: net income ÷ weighted average shares · filed 2016-12-14 |
| 2014-12-31 | -$0.41 10-K · filed 2016-12-14 | -$0.83 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$1.06 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$1.38 derived: net income ÷ weighted average shares · filed 2016-12-14 |
| 2014-09-30 | -$0.42 10-K · filed 2015-12-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$0.96 derived: net income ÷ weighted average shares · filed 2016-12-14 | -$1.25 10-K · filed 2016-12-14 |
| 2014-06-30 | -$0.22 10-K · filed 2015-12-14 | -$0.53 derived: net income ÷ weighted average shares · filed 2015-12-14 | -$0.81 10-Q · filed 2015-08-04 | -$1.15 derived: net income ÷ weighted average shares · filed 2015-12-14 |
| 2014-03-31 | -$0.31 10-K · filed 2015-12-14 | -$0.60 10-Q · filed 2015-05-11 | -$0.95 derived: net income ÷ weighted average shares · filed 2015-12-14 | -$1.20 derived: net income ÷ weighted average shares · filed 2015-12-14 |
| 2013-12-31 | -$0.28 10-K · filed 2015-12-14 | -$0.63 derived: net income ÷ weighted average shares · filed 2015-12-14 | -$0.88 derived: net income ÷ weighted average shares · filed 2015-12-14 | -$1.24 derived: net income ÷ weighted average shares · filed 2015-12-14 |
| 2013-09-30 | -$0.43 10-K · filed 2014-11-25 | -$0.60 derived: net income ÷ weighted average shares · filed 2015-12-14 | -$0.97 derived: net income ÷ weighted average shares · filed 2015-12-14 | -$1.30 10-K · filed 2015-12-14 |
| 2013-06-30 | -$0.23 10-K · filed 2014-11-25 | -$0.60 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$0.92 10-Q · filed 2014-08-12 | -$1.32 derived: net income ÷ weighted average shares · filed 2014-11-25 |
| 2013-03-31 | -$0.41 10-K · filed 2014-11-25 | -$0.74 10-Q · filed 2014-05-06 | -$1.16 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.82 derived: net income ÷ weighted average shares · filed 2014-11-25 |
| 2012-12-31 | -$0.33 10-K · filed 2014-11-25 | -$0.75 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.42 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.92 derived: net income ÷ weighted average shares · filed 2014-11-25 |
| 2012-09-30 | -$0.43 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.12 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.63 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.90 10-K · filed 2014-11-25 |
| 2012-06-30 | -$0.71 10-Q · filed 2013-08-07 | -$1.22 derived: net income ÷ weighted average shares · filed 2013-08-07 | -$1.48 10-Q · filed 2013-08-07 | |
| 2012-03-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2013-05-09 | -$0.75 derived: net income ÷ weighted average shares · filed 2013-05-09 | ||
| 2011-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2013-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |